Newlife to develop wristwatch heart rate monitor:
This article was originally published in Clinica
US company Newlife Technologies is to use technology licensed from BTG International to develop a wristwatch-like device that can noninvasively monitor vital signs in the human body, such as heart rate. The technology consists of an optical fibre sensor that can pick up physiological changes in the body through the strap, Steve Burton, Newlife's president told Clinica. The Midlothian, Virginia-based company will use the technology to enhance its FDA-approved heart rate monitoring product, the HEARTalker, which vocally feeds back ECG measurements from a strap worn around the chest to assist the user during personal training.
You may also be interested in...
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.